AVENZO THERAPEUTICS
Live / Allowed — Fifth extension granted (statement of use) (as of 25 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Sept 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97596314
- Mark type
- Word mark
- Filed
- 19 Sept 2022
- Published for opposition
- 28 Nov 2023
- Attorney of record
- Joyce Liou
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals, therapies, diseases, and disorders
Owner
- Avenzo Therapeutics, Inc., San Diego, CA, US
- Avenzo Therapeutics, Inc., San Diego, CA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 97596314 — Roche Molecular Systems, Inc. v. Avenzo Therapeutics, Inc., filed 19 Dec 2023 (Terminated)
Prosecution history
- 26 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Aug 2026 — SOU EXTENSION 5 GRANTED
- 21 Jul 2026 — SOU EXTENSION 5 FILED
- 25 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2026 — SOU EXTENSION 4 GRANTED
- 12 Mar 2026 — SOU EXTENSION 4 FILED
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2025 — SOU EXTENSION 3 GRANTED
- 24 Jun 2025 — SOU EXTENSION 3 FILED